newsfilter
← Latest News
PR Newswire·

POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination

  • POMDOCTOR LIMITED received a staff determination letter from Nasdaq on October 6, 2026, notifying the company of non-compliance with the minimum bid price requirement.
  • The company's American depositary shares traded below $1.00 per share for 30 consecutive business days between August 24, 2026, and October 5, 2026.
  • The company is ineligible for the standard 180-day compliance period because it executed a 1-for-18 reverse stock split on June 22, 2026, within the prior one-year period.
  • Unless the company appeals the determination, its securities will be suspended from trading on October 15, 2026, and Nasdaq will file a Form 25-NSE to delist the securities.
  • The company intends to request a hearing before the Nasdaq Hearings Panel by the October 13, 2026, deadline to present a plan for regaining compliance.
  • A timely hearing request will stay the suspension of trading 82the filing of the delisting form pending the Panel's decision.
  • The company is evaluating alternatives to regain compliance but offers no assurance that the Panel will grant an extension or that the appeal will be successful.